فاکتور ۲۳ رشد فیبروبلاست
برای مطالعهٔ بیشتر

Kiela PR, Ghishan FK (January 2009). "Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis". Laboratory Investigation; A Journal of Technical Methods and Pathology. 89 (1): 7–14. doi:10.1038/labinvest.2008.114. PMC 4292907. PMID 19029978.
Silve C, Beck L (June 2002). "Is FGF23 the long sought after phosphaturic factor phosphatonin?". Nephrology, Dialysis, Transplantation. 17 (6): 958–961. doi:10.1093/ndt/17.6.958. PMID 12032180.
Quarles LD (July 2003). "FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization". American Journal of Physiology. Endocrinology and Metabolism. 285 (1): E1–E9. doi:10.1152/ajpendo.00016.2003. PMID 12791601.
Fukagawa M, Nii-Kono T, Kazama JJ (July 2005). "Role of fibroblast growth factor 23 in health and in chronic kidney disease". Current Opinion in Nephrology and Hypertension. 14 (4): 325–329. doi:10.1097/01.mnh.0000172717.49476.80. PMID 15930999. S2CID 23555353.
Imel EA, Econs MJ (September 2005). "Fibroblast growth factor 23: roles in health and disease". Journal of the American Society of Nephrology. 16 (9): 2565–2575. doi:10.1681/ASN.2005050573. PMID 16033853. S2CID 8612881.
Liu S, Quarles LD (June 2007). "How fibroblast growth factor 23 works". Journal of the American Society of Nephrology. 18 (6): 1637–1647. doi:10.1681/ASN.2007010068. PMID 17494882.
White KE, Evans WE, O'Riordan JL, Speer MC, Econs MJ, Lorenz-Depiereux B, Grabowski M, Meitinger T, Strom TM,  et al. (ADHR Consortium) (November 2000). "Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23". Nature Genetics. 26 (3): 345–348. doi:10.1038/81664. PMID 11062477. S2CID 38870810.
White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Jüppner H, Econs MJ (February 2001). "The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting". The Journal of Clinical Endocrinology and Metabolism. 86 (2): 497–500. doi:10.1210/jcem.86.2.7408. PMID 11157998.
Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (May 2001). "Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia". Proceedings of the National Academy of Sciences of the United States of America. 98 (11): 6500–6505. Bibcode:2001PNAS...98.6500S. doi:10.1073/pnas.101545198. PMC 33497. PMID 11344269.
Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R, Schiavi SC (June 2001). "FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate". Biochemical and Biophysical Research Communications. 284 (4): 977–981. doi:10.1006/bbrc.2001.5084. PMID 11409890.
White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (December 2001). "Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23". Kidney International. 60 (6): 2079–2086. doi:10.1046/j.1523-1755.2001.00064.x. PMID 11737582.
Kruse K, Woelfel D, Strom TM (2002). "Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation". Hormone Research. 55 (6): 305–308. doi:10.1159/000050018 (inactive 2024-09-21). PMID 11805436. S2CID 46748089.{{cite journal}}:  CS1 maint: DOI inactive as of سپتامبر 2024 (link)
Yamashita T, Konishi M, Miyake A, Inui K, Itoh N (August 2002). "Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway". The Journal of Biological Chemistry. 277 (31): 28265–28270. doi:10.1074/jbc.M202527200. PMID 12032146.
Saito H, Kusano K, Kinosaki M, Ito H, Hirata M, Segawa H, Miyamoto K, Fukushima N (January 2003). "Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production". The Journal of Biological Chemistry. 278 (4): 2206–2211. doi:10.1074/jbc.M207872200. PMID 12419819.
Bai XY, Miao D, Goltzman D, Karaplis AC (March 2003). "The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency". The Journal of Biological Chemistry. 278 (11): 9843–9849. doi:10.1074/jbc.M210490200. PMID 12519781.
Larsson T, Zahradnik R, Lavigne J, Ljunggren O, Jüppner H, Jonsson KB (February 2003). "Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia". European Journal of Endocrinology. 148 (2): 269–276. doi:10.1530/eje.0.1480269. PMID 12590648.
Campos M, Couture C, Hirata IY, Juliano MA, Loisel TP, Crine P, Juliano L, Boileau G, Carmona AK (July 2003). "Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein". The Biochemical Journal. 373 (Pt 1): 271–279. doi:10.1042/BJ20030287. PMC 1223479. PMID 12678920.
| ن ب ونگارخانه PDB | ن ب ونگارخانه PDB |
| --- | --- |
الگو:PDB Gallery/8074: الگو:PDB Gallery/8074